Kolexia
Toubert Antoine
Médecine générale
Hôpital Saint-Louis
Paris, France
174 Activités
341 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Leucémies Leucémie aigüe myéloïde Maladies auto-immunes Leucémie myéloïde Maladie chronique Sclérodermie systémique Tumeurs hématologiques Syndromes myélodysplasiques

Industries

Servier
2 collaboration(s)
Dernière en 2018
BMS
1 collaboration(s)
Dernière en 2018
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M.
Blood cancer journal   21 décembre 2023
Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant natural killer T cell subset differentiation.
Nature communications   01 décembre 2023
Improved T- and B-Cell Neogenesis in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Combined with the Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (Rivo-cel)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Lymphopenia Confers Poorer Prognosis in Myelodysplastic Neoplasms (MDS) with Very Low and Low IPSS-M
65th ASH Annual Meeting Abstracts   02 novembre 2023
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
Nature communications   03 février 2023
Autologous organoid co-culture model reveals T cell-driven epithelial cell death in Crohn's Disease.
Frontiers in immunology   10 novembre 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.
Nature medicine   15 octobre 2022
Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II.
Frontiers in immunology   14 octobre 2022
A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders: A Phase II Study of Efficacy and Tolerance of Azacitidine (AZA) In MDS-associated Steroid Dependent/Refractory Systemic Auto-immune and Inflammatory Disorders (SAID)
Essai Clinique (Celgene)   03 octobre 2022
Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesis.
Kidney international   13 septembre 2022